FEMY

Maxim Group analyst Jason McCarthy maintained a Buy rating on Femasys (FEMY - Research Report) yesterday and set a price target of $5.00. The company's shares opened today at $1.20.According to TipRanks, McCarthy is an analyst with an average return of -39.6% and a 14.32% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as SELLAS Life Sciences Group, Immutep, and Actinium Pharmaceuticals.Femasys has an analyst consensus of Moderate Buy, with a price target consensus of $5.00, which is a 316.67% upside from current levels. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $5.00 price target.
https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-buy-rating-for-femasys-femy?utm_source=advfn.com&utm_medium=referral